These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34070941)

  • 1. Prognostic Genetic Biomarkers Based on Oncogenic Signaling Pathways for Outcome Prediction in Patients with Oral Cavity Squamous Cell Carcinoma.
    Fan WL; Yang LY; Hsieh JC; Lin TC; Lu MJ; Liao CT
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.
    Su SC; Lin CW; Liu YF; Fan WL; Chen MK; Yu CP; Yang WE; Su CW; Chuang CY; Li WH; Chung WH; Yang SF
    Theranostics; 2017; 7(5):1088-1099. PubMed ID: 28435450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
    Liao CT; Yang LY; Lee LY; Lin CY; Wang HM; Ng SH; Yen TC; Fan WL; Hsieh JC
    Oral Oncol; 2021 Nov; 122():105547. PubMed ID: 34700279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational landscape of penile squamous cell carcinoma in a Chinese population.
    Wang Y; Wang K; Chen Y; Zhou J; Liang Y; Yang X; Li X; Cao Y; Wang D; Luo L; Li B; Li D; Wang L; Liang Z; Gao C; Wang Q; Lv Q; Li Z; Shi Y; Niu H
    Int J Cancer; 2019 Sep; 145(5):1280-1289. PubMed ID: 31034097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
    Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
    Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
    Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
    Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation Between the Evolution of Somatic Alterations During Lymphatic Metastasis and Clinical Outcome in Penile Squamous Cell Carcinoma.
    Cao J; Yang CH; Han WQ; Xie Y; Liu ZZ; Jiang SS
    Front Oncol; 2021; 11():641869. PubMed ID: 34150614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise Identification of Recurrent Somatic Mutations in Oral Cancer Through Whole-Exome Sequencing Using Multiple Mutation Calling Pipelines.
    Lin LH; Chou CH; Cheng HW; Chang KW; Liu CJ
    Front Oncol; 2021; 11():741626. PubMed ID: 34912705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation.
    Tinhofer I; Stenzinger A; Eder T; Konschak R; Niehr F; Endris V; Distel L; Hautmann MG; Mandic R; Stromberger C; Weichert W; Budach V
    Ann Oncol; 2016 Dec; 27(12):2262-2268. PubMed ID: 27681865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
    Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations.
    Joshi A; Mishra R; Desai S; Chandrani P; Kore H; Sunder R; Hait S; Iyer P; Trivedi V; Choughule A; Noronha V; Joshi A; Patil V; Menon N; Kumar R; Prabhash K; Dutt A
    Oncotarget; 2021 Mar; 12(6):578-588. PubMed ID: 33796225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Exome Sequencing Analysis of Oral Squamous Cell Carcinoma Delineated by Tobacco Usage Habits.
    Patel K; Bhat FA; Patil S; Routray S; Mohanty N; Nair B; Sidransky D; Ganesh MS; Ray JG; Gowda H; Chatterjee A
    Front Oncol; 2021; 11():660696. PubMed ID: 34136393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
    Mountzios G; Rampias T; Psyrri A
    Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma.
    Hanna GJ; Woo SB; Li YY; Barletta JA; Hammerman PS; Lorch JH
    Int J Oral Maxillofac Surg; 2018 May; 47(5):568-577. PubMed ID: 28969885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
    Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
    Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.